Guide

Magnesium Forms Explained: Glycinate vs Citrate vs Threonate vs Oxide

Mar 28, 2026 · Updated Apr 24, 2026 · 8 min read

Magnesium is one of the most commonly recommended supplements, and for good reason: it is involved in over 300 enzymatic reactions in the body, roughly 48% of Americans do not meet the recommended daily intake, and deficiency is associated with poor sleep, anxiety, muscle cramps, elevated blood pressure, and impaired glucose regulation. But "magnesium" on a supplement label is not a single thing — it is a mineral that must be bound to a carrier molecule, and that carrier determines how much you actually absorb, where it acts, and what side effects you can expect.

Walking into a pharmacy and choosing between magnesium oxide, glycinate, citrate, malate, threonate, and taurate without guidance is genuinely confusing. Here is what the evidence says about the most clinically relevant forms.

Magnesium Forms Compared

Absorption and primary use case

Glycinate / bisglycinatebest-tolerated, sleep
High
Malateenergy, fibromyalgia
High
Citratealso a laxative
Moderate
L-threonatebrain uptake
Moderate
Oxide (bulk cheap)laxative only
Low
Sulfate (Epsom)transdermal: poor systemic
Minimal
Bottles labeled '500 mg magnesium' can mean 500 mg of the salt, not elemental Mg. Oxide is ~60% Mg but only ~4% of that absorbs.

Magnesium Oxide: The Most Common, Least Absorbed

Magnesium oxide is the cheapest form and the most prevalent in low-cost multivitamins and generic supplement products. A 500 mg tablet of magnesium oxide contains approximately 300 mg of elemental magnesium — a high percentage by weight, which makes it look efficient on labels. The problem is bioavailability: magnesium oxide has only about 4% bioavailability in most studies, meaning the vast majority passes through the gut unabsorbed.

What magnesium oxide is effective at is laxation. The unabsorbed magnesium draws water into the colon through osmosis, which is why magnesium oxide is the active ingredient in most osmotic laxatives (Phillips' Milk of Magnesia, for example). As a magnesium supplement for systemic effects — sleep, anxiety, muscle function, cardiovascular health — it is a poor choice. Many people take magnesium oxide, notice nothing, and conclude magnesium "doesn't work for them" when they were simply taking a largely inert form for systemic purposes.

Magnesium Citrate: Solid General Purpose

Magnesium citrate has bioavailability of approximately 25–30%, significantly higher than oxide. It is the most common recommendation for general magnesium supplementation and is a good all-purpose choice. The citrate form is well-tolerated, relatively inexpensive, and has good evidence across a range of outcomes including blood pressure reduction, muscle cramp prevention, and general magnesium repletion.

At higher doses (above 400–500 mg elemental magnesium), citrate can cause loose stools in some people — a useful signal that your dose exceeds what the gut can absorb in one sitting. For people seeking a general magnesium supplement and who do not have digestive sensitivity, citrate is usually the starting recommendation. Split dosing (morning and evening) improves tolerance and absorption at higher target doses.

Magnesium Glycinate: The Preferred Sleep and Anxiety Form

Magnesium glycinate is magnesium bound to glycine, an amino acid with its own inhibitory neurotransmitter properties (glycine acts on NMDA receptors and in the spinal cord). This combination makes magnesium glycinate particularly well-suited for sleep support and anxiety management, as both the magnesium and the glycine contribute to CNS calming through complementary mechanisms.

Bioavailability is high — estimated at 50–80% in some studies, though direct head-to-head human bioavailability comparisons are limited — and it is the most gentle on the digestive system of any common magnesium form. The near-absence of GI side effects makes it suitable for people who experience loose stools from citrate. At 300–400 mg elemental magnesium per night, glycinate is generally considered the gold standard form for sleep-specific applications.

The trade-off is cost: glycinate is typically 2–3 times more expensive per gram of elemental magnesium than citrate. For people using magnesium strictly for sleep or anxiety, this premium is arguably justified. For people replenishing a dietary deficit without specific CNS goals, citrate is a more economical choice.

Magnesium L-Threonate: The Brain-Targeted Form

Magnesium L-threonate is a newer, patented form developed by researchers at MIT. Its distinguishing claim is its ability to cross the blood-brain barrier and raise brain magnesium concentrations more effectively than other forms. This was demonstrated in preclinical studies (rats) where threonate significantly increased brain magnesium levels while other forms did not. Subsequent human trials showed modest improvements in cognitive flexibility, short-term memory, and quality of sleep in older adults.

The clinical evidence in humans is limited — two published trials, both from the same research group and with relatively small sample sizes. While the preclinical rationale is strong, independent replication in larger trials is needed before threonate can be confidently recommended over glycinate for brain-specific applications. It is also the most expensive magnesium form by a significant margin — often 4–5 times the cost of glycinate.

The practical situation: if you specifically want cognitive benefits from magnesium supplementation (not just sleep or muscle function), threonate is the most theoretically rational choice. If your goal is sleep, anxiety reduction, or general repletion, glycinate provides similar CNS benefit at lower cost.

Magnesium Malate: For Energy and Muscle

Magnesium malate is magnesium bound to malic acid, a compound that the body uses inside the Krebs cycle (the energy-making process in mitochondria). On paper, that makes it a reasonable pick for people looking for energy support or help with muscular endurance. Absorption is good and it is generally easy on the stomach. The human evidence base, though, is small. The most-cited study is Russell and colleagues' 1995 placebo-controlled crossover trial in the Journal of Rheumatology (24 patients with fibromyalgia, 4 weeks of blinded treatment followed by a 6-month open-label extension). During the blinded phase, 300 mg of malic acid plus about 150 mg of elemental magnesium per day did not beat placebo. Benefits only emerged during the open-label extension at higher doses. Bottom line: malate is a reasonable form, but the fibromyalgia claim rests on weak evidence and should be described that way.

Quick Reference

Sources

  1. Schuchardt JP, Hahn A. "Intestinal Absorption and Factors Influencing Bioavailability of Magnesium — An Update." Current Nutrition & Food Science, 2017;13(4):260-278. PMID: 29123461. DOI: 10.2174/1573401313666170427162740.
  2. Slutsky I, Abumaria N, Wu LJ, et al. "Enhancement of learning and memory by elevating brain magnesium." Neuron, 2010;65(2):165-177. PMID: 20152124. DOI: 10.1016/j.neuron.2009.12.026.
  3. Liu G, Weinger JG, Lu ZL, et al. "Efficacy and Safety of MMFS-01, a Synapse Density Enhancer, for Treating Cognitive Impairment in Older Adults: A Randomized, Double-Blind, Placebo-Controlled Trial." Journal of Alzheimer's Disease, 2016;49(4):971-990. PMID: 26519439. DOI: 10.3233/JAD-150538.
  4. Russell IJ, Michalek JE, Flechas JD, Abraham GE. "Treatment of fibromyalgia syndrome with Super Malic: a randomized, double blind, placebo controlled, crossover pilot study." Journal of Rheumatology, 1995;22(5):953-958. PMID: 8587088.
  5. DiNicolantonio JJ, Liu J, O'Keefe JH. "Magnesium for the prevention and treatment of cardiovascular disease." Open Heart, 2018;5(2):e000775. PMID: 30018772. DOI: 10.1136/openhrt-2018-000775.
  6. Boyle NB, Lawton C, Dye L. "The Effects of Magnesium Supplementation on Subjective Anxiety and Stress — A Systematic Review." Nutrients, 2017;9(5):429. PMID: 28445426. DOI: 10.3390/nu9050429.
  7. Zhang Y, Xun P, Wang R, et al. "Can Magnesium Enhance Exercise Performance?" Nutrients, 2017;9(9):946. PMID: 28846654. DOI: 10.3390/nu9090946.
  8. Rondanelli M, Faliva MA, Tartara A, et al. "An update on magnesium and bone health." BioMetals, 2021;34(4):715-736. PMID: 33959846. DOI: 10.1007/s10534-021-00305-0.
  9. Abbasi B, Kimiagar M, Sadeghniiat K, et al. "The effect of magnesium supplementation on primary insomnia in elderly: A double-blind placebo-controlled clinical trial." Journal of Research in Medical Sciences, 2012;17(12):1161-1169. PMID: 23853635.